reSee.it - Related Video Feed

Some antiparasitic drugs like mabendazole and ivermectin have shown effectiveness against certain cancers. Combining these drugs with others has led to the disappearance of solid tumors in some patients. It's not a single drug but a combination approach that yields results.

Ivermectin may have potential in fighting cancer by stopping the growth or killing certain cancer cells. Research suggests it could be effective against various cancers like breast, prostate, stomach, and others by inducing natural cell death. It is even used alongside chemotherapy for breast cancer. Consult your doctor before using Ivermectin. For more cancer-fighting tips, visit ehealthandu.com.

Ivermectin, a 62-year-old drug, has received a Nobel Prize for its unique properties. It has been found to block 8 pathways to cancer, making it a valuable repurposed drug in cancer treatment.

Ivermectin is a versatile drug with antiviral and anti-inflammatory properties that stimulate healing processes like autophagy and improve the microbiome. It is effective for early COVID treatment and vaccine injuries, and is affordable as a generic drug. Despite misconceptions, it is not a horse dewormer and has been available for as little as 2¢ per tablet through the WHO.

There is a drug called Ivermectin that has proven to be highly effective in combating the current crisis. This is not an exaggeration, but a scientific recommendation based on extensive data gathered over the past three months. The NIH's recommendation against using Ivermectin outside of controlled trials was made in August, but since then, numerous studies from various countries have shown its miraculous impact. It has been found to completely prevent the transmission of the virus and ensure that individuals who take it do not get sick.

I found over 100 scientific papers showing Ivermectin's potential against cancer, primarily from preclinical studies. Researchers are puzzled by how this anti-parasitic drug, which has been effective for decades, can also treat cancer. Ivermectin is off patent, meaning there's little financial incentive for big pharma to invest in its research. Notably, Ivermectin can kill cancer stem cells, reverse chemotherapy resistance, and enhance the effectiveness of both chemotherapy and radiation. Patients combining Ivermectin with these treatments have shown remarkable results, including significant tumor reductions. After two years of research, I now treat over 1,000 cancer patients with Ivermectin and other anti-parasitic drugs. The recent mention by Mel Gibson about friends curing stage 4 cancer with these treatments highlights the growing awareness of this approach.

Researchers in Melbourne may have discovered a potential cure for COVID-19 using a cheap and widely available head lice treatment called Ivermectin. Monash University's Dr. Kylie Wagstaff and her team found that Ivermectin can kill SARS-CoV-2 cells in a petri dish. This treatment has also shown effectiveness against other viruses like HIV, influenza, dengue fever, and Zika. While promising, it's important to note that Ivermectin is typically used as a horse dewormer.

Fenbendazole is an overlooked cancer drug with at least 12 proven anti-cancer mechanisms. It disrupts microtubule polymerization, induces cell cycle arrest, blocks glucose transport, increases tumor suppressor levels, inhibits cancer cell viability, migration, and invasion, induces apoptosis, autophagy, and necrosis, and inhibits angiogenesis and drug resistance. Mebendazole, a similar drug, is already approved by the FDA and in clinical trials for brain and colon cancers. However, there are no Fenbendazole clinical trials for cancer, likely because it is cheap, safe, and effective. Big pharma may not see a profit margin in it, which raises concerns about their motives. This highlights the issue of a society designed to make people sick, with pharmaceutical companies profiting from remedies.

Ivermectin, known for its use in treating COVID-19, has also shown promise in treating aggressive cancers such as glioblastomas, stage 4 breast and colon cancers, pancreatic cancers, gallbladder cancers, renal cancers, and melanomas. Research suggests that higher doses of Ivermectin can halt the growth and metastasis of these cancer cells, as well as induce apoptosis and autophagy to kill them. It is worth considering Ivermectin as a potential treatment for these aggressive cancers, in addition to its effectiveness against viral outbreaks.

Ivermectin was discovered in Tokyo by scientists Satoshi Omura and William C. Campbell. They found a bacteria in soil that could kill roundworms in mice, and after isolating its active compounds and making slight changes, they created Ivermectin. This drug has been widely used to treat river blindness in Africa since 1988, a disease that caused many people to lose their eyesight. Ivermectin works by penetrating the parasites' nervous system, disabling their neurons and causing them to die. It has had a significant impact on human health, with over 3.7 billion doses taken in the past 30 years.

I have three friends who had stage 4 cancer, and now they are cancer-free. They used treatments like Ivermectin, Fenbendazole, and methylene blue, which was originally a fabric dye but is now known to have significant effects on mitochondria. It's surprising to discover that many effective treatments are overlooked or demonized, raising questions about the motives behind our medical institutions. Why are these cures not promoted when they are not profitable?

A man diagnosed with terminal colon cancer saw significant improvement after taking Ivermectin alongside chemotherapy. His CEA levels dropped rapidly, and the number of tumors in his liver decreased from 25 to 3. Despite eventually succumbing to liver failure, his wife credits Ivermectin for extending his life beyond the initial prognosis. This anecdotal story highlights the potential benefits of Ivermectin in cancer therapy.

I am presenting a case series of three patients whose cancers went into remission after taking the antiparasitic drug fenbendazole, as detailed in a paper published in Clinical Oncology Case Reports. Fenbendazole is a veterinary medicine that interferes with microtubule formation during cell division, which may inhibit cancer cell proliferation. This suggests it could be a safe and effective option for cancer treatment. There is an urgent need for drug regulators to consider repurposing fenbendazole for human use, especially since other safe treatments have been approved quickly. Further research is necessary to establish its role as a chemotherapy option. The paper indicates that these three patients experienced significant improvement in their cancer conditions. For more details, refer to the full paper.

Ivermectin, a 62-year-old drug, has been recognized with a Nobel Prize for its unique properties. It effectively blocks 8 pathways to cancer, making it a valuable repurposed drug for cancer patients.

We discovered that Ivermectin can kill COVID-19 in primate cells. A single dose of the drug stopped the virus from replicating within 48 hours. Human trials are on the horizon, as the drug has been safely used for decades. Repurposing existing drugs like Ivermectin can speed up development by utilizing known safety profiles and administration methods. We are working on determining if these benefits can translate to treating COVID-19 in humans.

Ivermectin is taken seriously by oncology in the UK and has shown anti-cancer activity, along with other drugs like thalidomide, CBD, and artemisinins. Ivermectin has multiple anti-cancer mechanisms and is given to millions worldwide, reportedly saving two million people a year from blindness. Mebendazole and febendazole, similar anti-parasitics, also have crossover links. Anecdotal evidence suggests these are used when conventional therapies fail. Ivermectin has few side effects at doses several times higher than normal, while mebendazole may cause liver toxicity, so intermittent use is recommended. A concoction of both is used to extend cancer treatment efficacy. Studies are needed to determine if there is real benefit, identify which people respond, determine the best management protocol and dose, and create a database of when ivermectin works. Oncology is using very high doses compared to normal. Intermittent use may be better than constant exposure. Formal studies are needed to determine if intermittent ivermectin at normal doses with mebendazole/febendazole is better than continuous high-dose ivermectin.

Ivermectin, known for its use in treating COVID-19, has also shown promise in treating aggressive cancers like glioblastomas, stage 4 breast and colon cancers, pancreatic cancers, gallbladder cancers, renal cancers, and melanomas. Research suggests that higher doses of Ivermectin can halt the growth and metastasis of these cancer cells, inducing apoptosis and autophagy to kill them. It is worth considering Ivermectin as a potential treatment for these turbo cancers, in addition to its effectiveness against viral outbreaks.

Ivermectin, a 62-year-old drug, has been found to have multiple uses. It received a Nobel Prize for its unique abilities, including blocking eight pathways to cancer. As a result, Ivermectin is now being repurposed as a treatment for cancer patients.

Ivermectin, once considered a conspiracy theory, is now reportedly curing diseases like cancer, diabetes, MS, and Parkinson's by addressing parasites. The speaker prefers the dura mectin version, a white paste, over the ivermectin yellow gel. According to the speaker, no one has ever died from ivermectin overdose, unlike aspirin and acetaminophen. Ivermectin won a Nobel Prize in 2015 for its effectiveness against diseases like malaria. Positive effects were seen for COVID, but its use was discouraged to maintain the emergency declaration. The speaker takes a full capsule of ivermectin daily for two weeks, followed by a week off, as a prophylactic. They wash it down with a sweat tonic containing quinine, which is hydrochloroquine. Hydrochloroquine and ivermectin were allegedly dismissed by organizations like the WHO, despite being effective. Links to more information are provided in the comments.

Ivermectin, discovered by scientists Satoshi Omura and William C. Campbell, is a drug that kills parasites by disabling their neurons. It was originally used to treat river blindness in Africa, a disease that caused many people to lose their eyesight. Thanks to Ivermectin, this disease is now close to being eliminated. The drug has had a significant impact on human health and is considered second only to penicillin. Over the past 30 years, humans have taken approximately 3.7 billion doses of Ivermectin.

Ivermectin, a Nobel Prize-winning anti-parasitic drug, has been vilified. Merck, who held the patent until 1996, claims it doesn't work for COVID-19. However, Merck has a 50/50 partnership with Moderna on mRNA cancer vaccines. Because Merck will make billions on mRNA cancer vaccines, they have no interest in investigating ivermectin for cancer. There is evidence that high-dose ivermectin is effective in treating many types of cancers.

The speaker focuses on treating stage four cancer patients, often with late diagnoses. They use ivermectin combined with fenbendazole or mebendazole, both antiparasitics, even in early-stage breast cancer cases before surgery. The speaker claims that stage four cancers, including pancreatic, ovarian, and melanoma, have responded, with some patients becoming cancer-free. Tumors reportedly shrink significantly within months when patients take ivermectin and mebendazole before surgery. The speaker notes that ivermectin and fenbendazole are inexpensive, off-patent drugs, but customs in British Columbia and Mississauga are allegedly confiscating packages. A published paper supports the use of ivermectin and fenbendazole in cancer treatment. The speaker treated a friend of Mel Gibson, who then shared the story on Joe Rogan's podcast. Ivermectin is described as a chemo and radio sensitizer. The speaker faced backlash from a pancreatic cancer support group for sharing a patient's story. The speaker claims to have patients in hospice who are now cancer-free and one patient who was offered medical assistance in dying but is now cancer-free. The speaker recounts a case where a patient with terminal melanoma and liver failure stabilized and improved with ivermectin and fenbendazole. Oncologists are portrayed as limited to expensive, profitable treatments.

- It acts on these signaling pathways called PAC-one and ACT and MTOR and WNT pathways, these are pathways that are involved in tumor proliferation, tumor growth. - ivermectin inhibits multiple of these pathways that inhibit tumor growth, tumor proliferation, leads to cell cycle arrest, and it also inhibits metastases and the ability of the tumors to create blood vessels for themselves. - Then ivermectin also acts on cancer stem cells. It inhibits cancer stem cells. - They're involved in metastases, and they're involved in cancer recurrence. - cancer stem cells tend to be resistant to chemo. And then your cancer comes roaring back because these cancer stem cells start proliferating again. - So it inhibits cancer stem cells, very important. - Ivermectin also reverses multi drug resistance. So if you develop resistance to certain chemotherapy, Ivermectin will reverse it and Ivermectin acts in combination with chemo or radiation therapy. - Guzzo 2002 safety study: "the conclusion was that ivermectin was generally well tolerated with no indication of CNS toxicity." - up to two milligrams per kilogram per day.

Ivermectin, the controversial anti-parasitic drug, has shown potential in stopping the growth or killing certain cancer cells. Research suggests that it may be effective against various types of cancer, including breast, prostate, stomach, colon, liver, lung, kidney, and leukemia. Ivermectin induces apoptosis, or natural cell death, in cancer cells. It is even being used alongside chemotherapy for breast cancer. However, it is important to consult with your doctor before considering Ivermectin for any purpose. For more information on fighting cancer, you can watch a lecture by Dr. Shintani at ehealthandu.com. This is Dr. Chintani, a board-certified MD and nutritionist trained at Harvard, signing off for your health.

Speaker 1 notes that ivermectin has broken through to the public sphere beyond COVID and is now discussed for many diseases. Speaker 0 asks where ivermectin stands in the scientific and medical community today and what other use cases exist for the medicine. Speaker 1 responds that thousands of doctors follow their data; 18,000 GI doctors see their data when they publish or present at the American College of Gastroenterology. Word-of-mouth in the medical community is a major form of marketing, with one doctor speaking to another. Referencing the COVID era, Speaker 1 mentions corruption and retractions, then describes ivermectin as having created a healthcare revolution where doctors have lined up to work to see other benefits of ivermectin without needing to ask permission to treat patients. A whole branch of healthcare is moving away from the same institute that Speaker 1 helped create drugs to market with his sisters. He says a group of doctors who had sponsored or helped pharma are turning away from pharma and exploring other methods to treat patients. He states his job is to unite doctors to see the truth, while bringing pharma back to being righteous and stopping data manipulation and scientist censorship. Speaker 1 references his book, Let’s Talk SH.T, acknowledging he could be wrong and challenging others to prove him wrong and reproduce the data to retract the hypothesis or paper. He emphasizes that the scientific process should be followed, especially when everything was done by the book and as well as he could. He adds that the research was not funded by others; it was funded by his savings. He created the microbiome research foundation with the goal of raising money to study kids with autism and to push an IND to the FDA, which cost about $600,000 to obtain FDA approval. He clarifies that no external party paid for this work, and he continues to struggle to raise funds to treat poor autistic kids who cannot afford expensive stool testing, drugs, and vitamins; they need help and everyone should step in to assist these kids. Speaker 1 concludes that their focus is fixing autism, with the aim of later addressing Parkinson’s, Alzheimer’s, and cancer.